Opportunity stated: "I am anxious to see how rapid Dr Moro will progress once he gets the shareholder approval."
I will tell you what will happen after shareholder approval. Exactly NOTHING.
The public offering is awaiting approval of the recently filed S-1 and that is the next step. Nothing will move forward until that filing is approved. As the OTC Journal stated, that process could take one to six months depending upon any revisions the SEC deems to require.
The fact that Moro did not even mention the Abbott amendment is not a good start. The SEC probably will not find that to be acceptable since the previous registration fling required changes to include the confidential license agreements. If the SEC previously required the Abbott license agreement to be disclosed, they are certainly going to want the amended license agreement to be at least mentioned in the new S-1.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.